Bone Biologics Corp Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bone Biologics Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Bone Biologics Corp Entity Common Stock, Shares Outstanding for the quarter ending November 14, 2024 was 2.46M shares, a 21.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.46M -671K -21.4% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 1.8M -1.33M -42.5% Aug 9, 2024 10-Q 2024-08-09
Q1 2024 1.1M -15.6M -93.4% May 9, 2024 10-Q 2024-05-14
Q4 2023 534K Feb 14, 2024 10-K 2024-02-21
Q3 2023 3.13M -12.2M -79.5% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 3.13M -7.22M -69.7% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 16.7M +6.35M +61.4% Mar 28, 2023 10-K/A 2023-11-20
Q3 2022 15.3M +5M +48.6% Nov 2, 2022 10-Q 2022-11-14
Q2 2022 10.4M -20.3M -66.3% Aug 11, 2022 10-Q 2022-08-11
Q1 2022 10.4M -20.3M -66.3% Feb 28, 2022 10-K 2022-03-15
Q3 2021 10.3M Oct 29, 2021 10-Q 2021-11-15
Q2 2021 30.7M Jul 31, 2021 10-Q 2021-08-16
Q1 2021 30.7M 0 0% Mar 31, 2021 10-K 2021-04-15
Q1 2020 30.7M +2.74M +9.82% Mar 25, 2020 10-K 2020-03-30
Q3 2019 30.7M +22.2M +264% Nov 1, 2019 10-Q 2019-11-14
Q2 2019 30.7M +22.4M +269% Aug 8, 2019 10-Q 2019-08-14
Q1 2019 27.9M -15.7M -36% Mar 25, 2019 10-K 2019-03-29
Q3 2018 8.44M -30.6M -78.4% Nov 12, 2018 10-Q 2018-11-16
Q2 2018 8.32M -30.5M -78.6% Aug 2, 2018 10-Q 2018-08-14
Q1 2018 43.7M +4.85M +12.5% Mar 12, 2018 10-K 2018-04-02
Q3 2017 39.1M +249K +0.64% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 38.8M 0 0% Aug 4, 2017 10-Q 2017-08-08
Q1 2017 38.8M +814K +2.14% Mar 16, 2017 10-K 2017-03-30
Q3 2016 38.8M +6.75M +21% Nov 5, 2016 10-Q 2016-11-14
Q2 2016 38.8M +7.86M +25.4% Aug 5, 2016 10-Q 2016-08-15
Q1 2016 38M +13.7M +56.6% Mar 14, 2016 10-K 2016-03-28
Q3 2015 32.1M +27.1M +542% Nov 14, 2015 10-Q 2015-11-16
Q2 2015 31M +26M +519% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 24.3M +19.3M +385% Mar 30, 2015 10-K 2015-03-31
Q4 2014 24.3M +19.3M +385% Nov 19, 2014 10-Q 2014-11-19
Q3 2014 5M 0 0% Sep 14, 2014 10-Q 2014-09-15
Q2 2014 5M 0 0% Jun 23, 2014 10-Q 2014-06-23
Q1 2014 5M 0 0% Mar 17, 2014 10-Q 2014-03-17
Q4 2013 5M 0 0% Feb 13, 2014 10-K 2014-02-13
Q3 2013 5M 0 0% Sep 11, 2013 10-Q 2013-09-11
Q2 2013 5M 0 0% Jun 14, 2013 10-Q 2013-06-14
Q1 2013 5M 0 0% Mar 18, 2013 10-Q 2013-03-18
Q4 2012 5M 0 0% Jan 29, 2013 10-K 2013-01-29
Q3 2012 5M 0 0% Sep 14, 2012 10-Q 2012-09-14
Q2 2012 5M Jun 14, 2012 10-Q 2012-06-14
Q1 2012 5M Mar 16, 2012 10-Q 2012-03-16
Q4 2011 5M Jan 30, 2012 10-K 2012-01-30
Q3 2011 5M Sep 14, 2011 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.